title: EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.
abstract: Ephrin family receptor tyrosine kinases are mediators of angiogenesis that may also regulate endothelial barrier function in the lung. Previous work has demonstrated that stimulation of EphA ephrin receptors causes increased vascular leak in the intact lung and increased permeability in cultured endothelial cells. Whether EphA receptors are involved in the permeability changes associated with lung injury is unknown. We studied this question in young rats exposed to viral respiratory infection combined with exposure to moderate hypoxia, a previously described lung injury model. We found that the EphA2 receptor is expressed in normal lung and that EphA2 expression is markedly upregulated in the lungs of hypoxic infected (HV) rats compared with normal control animals. Immunohistochemistry showed increased EphA2 expression principally in areas of edematous alveolar septae. In HV rats, EphA2 antagonism with either the soluble decoy receptor EphA2/Fc or with monoclonal anti-EphA2 antibody reduced albumin extravasation and histological evidence of edema formation (P<0.01). Vascular leak in HV rats is mediated in large part by increased lung endothelin (ET) levels. In HV rats, ET receptor antagonism with bosentan resulted in reduced EphA2 mRNA and protein expression (P<0.01). Experiments with cultured rat lung microvascular endothelial cells demonstrated that ET increases endothelial EphA2 expression. These results suggest that EphA2 expression is increased in lung injury, contributes to vascular leak in the injured lung, and is regulated in endothelial cells by ET. EphA2 may be a previously unrecognized contributor to the pathophysiology of lung injury.
authors.affiliation: Developmental Lung Biology Laboratory, Box B-131, Department of Pediatrics, University of Colorado School of Medicine, 12700 East 19th Ave., Aurora, CO 80045, USA.
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Cercone
authors.forename: William
authors.initials: W
authors.lastname: Schroeder
authors.forename: Stacey
authors.initials: S
authors.lastname: Schomberg
authors.forename: Todd C
authors.initials: TC
authors.lastname: Carpenter
mesh_terms: D000818:Animals; D002199:Capillary Permeability / Q000502:physiology*; D004487:Edema / Q000150:complications / Q000473:pathology; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology; D016232:Endothelins / Q000378:metabolism; D036382:Ephrin-A1 / Q000378:metabolism; D000860:Hypoxia / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D008168:Lung / Q000098:blood supply / Q000378:metabolism / Q000503:physiopathology; D055370:Lung Injury / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000821:virology*; D008297:Male; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D036104:Receptor, EphA2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D014777:Virus Diseases / Q000150:complications* / Q000473:pathology / Q000503:physiopathology*
chemical_list: D016232:Endothelins; D036382:Ephrin-A1; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D036104:Receptor, EphA2
references.citation: FASEB J. 2005 Nov;19(13):1884-6
references.pmid: 16166198
references.citation: Cell Signal. 2008 Dec;20(12):2256-65
references.pmid: 18814847
references.citation: J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49
references.pmid: 15054110
references.citation: J Biol Chem. 1997 Jul 4;272(27):17097-103
references.pmid: 9202027
references.citation: J Cell Sci. 2008 Feb 1;121(Pt 3):358-68
references.pmid: 18198190
references.citation: J Biol Chem. 1998 Sep 18;273(38):24670-5
references.pmid: 9733765
references.citation: J Appl Physiol (1985). 1998 Mar;84(3):1048-54
references.pmid: 9480968
references.citation: Oncogene. 2002 Oct 10;21(46):7011-26
references.pmid: 12370823
references.citation: Physiol Genomics. 2007 Dec 19;32(1):74-81
references.pmid: 17895394
references.citation: Exp Biol Med (Maywood). 2006 Jun;231(6):960-6
references.pmid: 16741031
references.citation: Curr Vasc Pharmacol. 2005 Oct;3(4):309-14
references.pmid: 16248773
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L431-9
references.pmid: 18599503
references.citation: Mol Cancer Res. 2002 Nov;1(1):2-11
references.pmid: 12496364
references.citation: Crit Care Med. 2006 Jun;34(6):1647-53
references.pmid: 16625129
references.citation: Circ Res. 2003 Sep 5;93(5):456-63
references.pmid: 12919946
references.citation: Stain Technol. 1990;65(2):95-101
references.pmid: 2360216
references.citation: Mol Immunol. 2008 Mar;45(5):1208-20
references.pmid: 17980912
references.citation: Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s43-50
references.pmid: 18174448
references.citation: Pharmacol Rev. 2007 Jun;59(2):185-205
references.pmid: 17540906
references.citation: Am J Physiol Lung Cell Mol Physiol. 2000 Sep;279(3):L547-54
references.pmid: 10956630
references.citation: J Thromb Thrombolysis. 2008 Jun;25(3):259-64
references.pmid: 17554593
references.citation: Science. 1995 Apr 28;268(5210):567-9
references.pmid: 7536959
references.citation: PLoS Med. 2006 Mar;3(3):e113
references.pmid: 16441182
references.citation: Physiol Genomics. 2005 Apr 14;21(2):152-60
references.pmid: 15671251
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Dec;289(6):L1075-82
references.pmid: 16040626
references.citation: Respirology. 2007 Sep;12(5):740-3
references.pmid: 17875064
references.citation: Brain Pathol. 2005 Jan;15(1):35-45
references.pmid: 15779235
references.citation: FASEB J. 2005 Oct;19(12):1689-91
references.pmid: 16081502
references.citation: J Biol Chem. 2002 Aug 2;277(31):27850-5
references.pmid: 12023962